Riociguat is generally safe and effective for PAH patients with coexisting cardiac and metabolic conditions, a trials ...

ECMO or ventilator use was the most significant predictor of mortality in patients undergoing lung transplant for idiopathic ...

In addition to being diagnosed more frequently in older patients, pulmonary arterial hypertension (PAH) is more frequently ...

The trial results indicated minimal adverse events and no evidence of immune-mediated clearance following TX45 treatment.

The move will enable the country’s more than 100 million chronic pulmonary disease patients to access free annual check-ups.

Tectonic recently announced the U.S. Food and Drug Administration cleared its Investigational New Drug application for TX45. Screening for the Phase 2 APEX clinical trial has been initiated and ...

Influenza-complicated thromboembolism (TE) among patients with severe influenza infection in the intensive care unit (ICU) is associated with increased risk for longer- duration mechanical ventilation ...

Regarded mostly as a lung disease, PAH is often in people with fewer nail fold capillaries, suggesting a disease of the small ...

BACKGROUND: The European Chronic Thromboembolic Pulmonary Hypertension registry (CTEPH), conducted between 2007 and 2012, reported the major impact of pulmonary endarterectomy (PEA) on the long-term ...

Although advancements have been made in treatment, many sickle cell disease warriors still face difficulties accessing ...

Researchers identified several inflammatory circulating proteins that could be useful biomarkers for predicting outcomes in ...

Katrina Berry was 24 years old when she first started experiencing symptoms of pulmonary arterial hypertension (PAH), a ...